Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virscidian is a laboratory informatics and analytical software company focused on automating chromatography and mass spectrometry workflows used in drug discovery and other R&D settings. Its core platform, Analytical Studio, converts raw LC/MS and related analytical data into standardized, decision-ready outputs for applications such as high-throughput purification, compound quality control, reaction screening, affinity selection by mass spectrometry, and DMPK workflows. The company serves pharmaceutical, biopharmaceutical, and broader scientific R&D customers with vendor-agnostic, configurable software and integration capabilities, including REST API-based connectivity to other laboratory systems. Virscidian was acquired by Dotmatics in September 2024 and continues to operate as part of Dotmatics' scientific software portfolio. The business is commercial-stage and is used by major pharma customers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Virscidian.